CRACW
Crown Reserve Acquisition Corp. IWarrants of Crown Reserve Acquisition Corp. I · CRAC stock page →
No price
Since first trade
+3.7%
from $9.90 · Dec 9
30 days
+0.3%
from $10.24
Range since listing
$9.89–10.28
−0% from high · low Dec 12
Avg volume 20D
37.2K
Oct 6 spike 265.2K
Short interest
3.1K
−26.1%
Days to cover
2.0
at average volume
Price
Daily candles with volume. Pins mark insider trades, rating changes, 13F stakes, reports, catalysts and short-interest jumps.
No data for this timeframe.
- X Aug 14 Short interest falls 27.6% to 4.5K
- X Oct 15 Short interest falls 26.1% to 3.1K
Signal stack
Where each data set points today.
- Short sellersCOVERING
Short interest −26.1% to 3.1K shares. 2.0 days to cover.
- TrendUPTREND
0% above its 50-day average. New closing high $10.28 on Oct 22.
Who's buying
13F| Top holder | Shares | Value |
|---|---|---|
| Magnetar Financial LLC | 742,500 | $39.1K |
| TORONTO DOMINION BANK | 807,000 | $32.3K |
| WOLVERINE ASSET MANAGEMENT LLC | 207,951 | $8.4K |
| COMMONWEALTH OF PENNSYLVANIA PUBLIC SCHOOL EMPLS RETRMT SYS | 141,860 | $7.4K |
| LINDEN ADVISORS LP | 125,000 | $6.6K |
| Hudson Bay Capital Management LP | 150,000 | $6.0K |
| Clear Street Group Inc. | 142,100 | $5.7K |
| BNP PARIBAS FINANCIAL MARKETS | 90,625 | $4.8K |
Quarterly 13F filings are due 45 days after each quarter ends.
Catalysts
Scheduled dates and disclosed events: earnings, FDA and trial readouts, halts, press releases. Colored dot = impact.
Recent
Earnings setup
Estimates| Period | EPS est. | Range | 30D rev. | Revenue |
|---|---|---|---|---|
| Current Q | None | None | No data | $0.00 |
| Next Q | None | None | No data | $0.00 |
| Current FY | None | None | No data | $0.00 |
| Next FY | None | None | No data | $0.00 |
Short side
FINRA· Oct 15, 20263,077
shares short
-26.1%
vs prior settlement
2.0
days to cover
Recent activity
The latest filings, insider trades, analyst actions, press and options flow, newest first.
Mar 31, 2026 Announcement
Crown Reserve Acquisition Corp. I and Carvix, Inc. Announce Definitive Business Combination Agreement
Transaction Values Carvix at $1.0 Billion Implied Enterprise Value; Combined Company Expected to Tra